Danh Phung

Danh Phung

Auto-generated profile, based on publicly available information

Danh Phung

Department of Pathology, Oslo University Hospital and University of Oslo, Oslo, Norway

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RBRaquel Bartolomé-Casado
Raquel Bartolomé-Casado
OLOle J.B. Landsverk
Ole J.B. Landsverk
SCSudhir Kumar Chauhan
Sudhir Kumar Chauhan
LRLisa Richter
Lisa Richter
DPDanh Phung
Danh Phung
FJFrode L. Jahnsen
Frode L. Jahnsen
Resident memory CD8 T (Trm) cells have been shown to provide effective protective responses in the small intestine (SI) in mice. A better understanding of the generation and persistence of SI CD8 Trm cells in humans may have implications for intestinal immune-mediated diseases and vaccine development. Analyzing normal and transplanted human SI, we demonstrated that the majority of SI CD8 T cells were bona fide CD8 Trm cells that survived for >1 yr in the graft. Intraepithelial and lamina propria CD8 Trm cells showed a high clonal overlap and a repertoire dominated by expanded clones, conserved both spatially in the intestine and over time. Functionally, lamina propria CD8 Trm cells were potent cytokine producers, exhibiting a polyfunctional (IFN-γ+ IL-2+ TNF-α+) profile, and efficiently expressed cytotoxic mediators after stimulation. These results suggest that SI CD8 Trm cells could be relevant targets for future oral vaccines and therapeutic strategies for gut disorders.

15 April 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
TSTor Espen Stav-Noraas
Tor Espen Stav-Noraas
REReidunn J. Edelmann
Reidunn J. Edelmann
LPLars La Cour Poulsen
Lars La Cour Poulsen
OSOlav Sundnes
Olav Sundnes
DPDanh Phung
Danh Phung
Johanna Hol FosseJohanna Hol Fosse
Johanna Hol Fosse
IL-33, required for viral clearance by cytotoxic T cells, is generally expressed in vascular endothelial cells in healthy human tissues. We discovered that endothelial IL-33 expression was stimulated as a response to adenoviral transduction. This response was dependent on MRE11, a sensor of DNA damage that can also be activated by adenoviral DNA, and on IRF1, a transcriptional regulator of cellular responses to viral invasion and DNA damage. Accordingly, we observed that endothelial cells responded to adenoviral DNA by phosphorylation of ATM and CHK2 and that depletion or inhibition of MRE11, but not depletion of ATM, abrogated IL-33 stimulation. In conclusion, we show that adenoviral transduction stimulates IL-33 expression in endothelial cells in a manner that is dependent on the DNA-binding protein MRE11 and the antiviral factor IRF1 but not on downstream DNA damage response signaling.